Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06).

Signal Transduct Target Ther · 2025 · PMC12297320 · PMID 40715072

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Low immune infiltrate density correlated with adverse outcomes, particularly CD8 + T cell depletion showing borderline significance (Supplementary Fig. 5 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.